Introduction
Lysozyme is a ubiquitous enzyme in milk, saliva, tears of most mammals, and avian egg whites [14]. It is an enzyme that degrades the bacterial cell wall by catalyzing the hydrolysis of β-(1,4)-glycosidic linkages between N-acetylmuramic acid and N-acetyl glucosamine found in the peptidoglycan layer, which is the major component of the cell wall of both gram-positive and gram-negative bacteria [21].
Based on its primary structure, three major classes of animal lysozymes have been identified as the chicken (C) type, the goose (G) type, and the invertebrate (I) type [2]. Although the overall sequence similarity of lysozymes in the different classes is low, they share a similar overall three-dimensional structure, and they have been proposed to have a common ancestry [11].
The major function of lysozymes in most organisms is to provide antibacterial protection, because hydrolysis of peptidoglycan will compromise the integrity of the cell wall and cause cell lysis. Owing to the bactericidal activity and thermal stability, lysozyme has been of interest in medicine, cosmetics, and the food industry. The most important application of lysozyme is usage as a food preservative, such as in cheese, fish, meat, fruit, vegetables, and wine.
Great progress has been made for lysozyme production in previous studies. Bacteriophage T4 lysozyme has been purified using the Ni-chelate affinity chromatography technique from overexpressing Escherichia coli cells [6]. Hen egg white lysozyme is produced at the metric ton scale by purification from eggs, and recent advances in transgenic plant technologies have led to similarly low production costs for recombinant human lysozyme [31]. Human lysozyme has also been expressed in Escherichia coli [16], Saccharomyces cerevisiae [12], and Pichia pastoris [28].
E. coli is a preferred host in heterologous protein expression. E. coli has the ability to grow rapidly at high density on inexpensive substrates, and it has well-characterized genetics, and a large number of cloning vectors and mutant host strains [27,33,34]. However, the E. coli expression system still has disadvantages. For example, it is a pathogenic bacterium and has endotoxins(lipopolysaccharide) [20]; it secretes protein into the periplasm and often into inclusion bodies [3,35]. As an alternative, Bacillus species are among the champions in secreted enzyme production. In biotechnological processes for protein production, Bacillus subtilis is the most popular host owing to its excellent fermentation properties, and huge capacity for secreting proteins directly into the growth medium, which offers major advantages in their downstream processing, and is non-pathogenic and free of endotoxins and offers non-biased codon usage [5,25,26,29,32].
The uses of chemical preservatives and antibiotics for eed and food additives are a critical problem to the health and environment. Consumer demand for natural origin, safe, and environmentally friendly food preservatives has been increasing recently. In this study, we have cloned the lysozyme gene of Bacillus licheniformis, a generally regarded as safe strain. The lysozyme was purified and characterized. The enzyme activity and antimicrobial spectrum were examined. The production of lysozyme in Bacillus subtilis WB800 was optimized.
Materials and Methods
Bacterial Strains and Culture Conditions
E. coli DH5α was used as a host for the construction of expression vector. E. coli BL21 (DE3) and Bacillus subtilis WB800 were used as a host for lysozyme expression. Bacillus subtilis WB800 was kindly provided by Prof. Hui Song (Tianjin Institute of Industrial Biotechnology, CAS). E. coli and Bacillus subtilis WB800 were cultured at 37℃ in Luria–Bertani medium (yeast extract, 5 g/l; peptone, 10 g/l; NaCl, 10 g/l; and agar, 15 g/l) containing suitable antibiotics. The cultures were incubated in 250 ml conical flasks containing 50 ml of culture broth on a rotary shaker at 200 rpm and 37℃.
Plasmids Construction
The primers and plasmids used in this study are summarized in Tables 1 and 2, respectively. Amplification of the lysozyme gene from chromosomal DNA of B. licheniformis was carried out by polymerase chain reaction (PCR) using gene-specific primers. For expression of lysozyme in E. coli, the lysozyme gene was amplified and inserted into the pET21b vector, and the cloning sites of NdeI and XhoI were introduced into the primers lysoE-F and lysoE-R for ligating into the pET21b-lyso vector.
Table 1.Note: capital letters represent restriction enzyme sites.
Table 2.Plasmids used in this study.
To produce the lysozyme in Bacillus subtilis WB800, promoter P43 and an amy signal peptide, promoter P43 and the sacB signal peptide, and promoter P43 and the PsacB-sacB signal peptide were fused by PCR using primers listed in Table 1, respectively. The plasmid list is shown in Table 2 and the diagram of plasmid construction is shown in Fig. 1. Plasmid pGJ104 was constructed by inserting promoter P43 and amy signal peptide into plasmid pGJ103. Plasmid pGJ105 was constructed by inserting promoter P43 and sacB signal peptide into plasmid pGJ103. Plasmid pGJ106 was constructed by inserting promoter P43, promoter sacB, and the amylase signal peptide into plasmid pGJ103. The lysozyme gene was amplified by using genomic DNA of B. licheniformis TIB320 as the template. The cloning sites of EcoRI and BamHI were introduced into the primers lyso-F and lyso-R for construction of pGJ201, pGJ202, and pGJ203, respectively.
Fig. 1.Schematic diagram elucidating the construction of plasmids applied in this study for expression of lysozyme in B. subtilis. Abbreviations: P43, the P43 promoter; amy, the amylase signal peptide; sacB, the sacB signal peptide; PsacB, the sacB gene promoter; Lyso, the lysozyme gene of Bacillus licheniformis TIB320.
Expression of Lysozyme in E. coli and Bacillus subtilis WB800
The recombinant plasmid pET21b-lyso was electrotransformed into E. coli BL21 (DE3) and cultured at 37℃ in LB medium (10 g/l tryptone, 5 g/l yeast extract, and 10 g/l NaCl) containing ampicillin (100 mg/l). The strain culture was incubated with rotary shaking for 12 h, and then 1% of the strain culture was transferred into fresh LB medium. When the culture OD was 0.6, 1 mmol/l (final concentration) isopropyl-/3-D-thiogalactosids (IPTG) was added to the expression culture for inducing the expression of lysozyme, with rotary shaking for 12 h at 30℃. After centrifugation at 12,000 ×g for 10 min at 4℃, the cells were collected and crushed for enzyme assays. The lysozyme activity in the supernatant was used to indicate the expression level.
The recombinant plasmids pGJ201, pGJ202, and pGJ203 were electrotransformed into B. subtilis WB800 and cultured at 37℃ in super-rich medium (25 g/l tryptone, 20 g/l yeast extract, 30 g/l glucose, and 3 g/l K2HPO4, pH 7.0) containing chloromycetin (10 μg/ml), respectively. The culture was cultivated for 72 h and samples were collected every 6 h. After centrifugation at 12,000 ×g for 5 min at 4℃, the supernatant was used for enzyme assays.
Expression and Purification of Lysozyme
The E. coli BL21 (DE3) harboring pET21b-lyso strain was grown in LB medium supplemented with 100 mg/l ampicillin. The cells were grown aerobically in 1 L Erlenmeyer flasks containing 200 ml of medium at 37℃ and 200 rpm in an orbital incubator shaker. The cells were induced at ~0.6 OD600 with 1 mM IPTG and incubated at 25℃ for 16 h. The cells were then harvested by centrifuging at 12,000 ×g for 10 min. The pellet was washed twice with 50 mM potassium phosphate buffer (pH 8.0) and resuspended in binding buffer (20 mM sodium phosphate buffer containing 0.5 M NaCl and 20 mM imidazole). The cells were cracked using an Ultrasonic instrument, and the cell lysate was centrifuged at 12,000 ×g at 4℃ for 30 min to remove the particulate fraction. The soluble fraction was subjected to purification under non-denaturing conditions by Ni-affinity chromatography using a Ni-NTA-HP resin column (GE Healthcare, Sweden). The elution from the column was pooled and dialyzed using a 10 kDa cutoff membrane to remove the salts. The extract was stored at -80℃.
Measurement of Enzymatic Activity of Lysozyme
Lysozyme activity was measured according to Hultmark et al.[13]. The enzymatic activity of lysozyme was determined by measuring the clearing of turbidity of Micrococcus lysodeikticus suspension (substrate solution) at 570 nm. A decrease in absorbance of 0.001 per minute was defined as 1 U enzymatic activity compared with the control. Standard strains of Micrococcus lysodeikticus as the substrate, and the optimum pH and temperature of lysozyme were measured. Firstly, dried M. lysodeikticus cells were suspended in 50 mM phosphate buffer (OD570 reached about 0.3). Then 1 ml of the lysozyme was added to 2 ml of bacterial suspension in an ice-bath. These were rapidly mixed and transferred to the cuvette, and the absorbance value was read at 570 nm, denoted by A0. Then the mixture was incubated for 30 min at 37℃, and placed on ice for 10 min to terminate the reaction. The absorbance value was read and denoted by A. The relative enzymatic activity of the lysozyme was obtained: UL = (A0 − A)/A.
Characterization of Lysozyme
The optimal pH was determined by examining the activity of the enzyme in Tris-HCl buffer. The pH value was regulated by KH2PO4 and K2HPO4 and was a range of 3-9 in 1 pH increments. Thermostability of the purified enzyme was determined by pre-incubating for 60 min at the temperatures ranging from 20℃ to 80℃. Then the residual activity was analyzed.
SDS-PAGE
SDS–polyacrylamide gel electrophoresis was performed in 12% gel according to the method of Laemmli [15]. The resulting gel was stained with 0.1% Coomassie Brilliant Blue R-250 in 45% methanol and 10% glacial acetic acid for 3 h and destained with 45% methanol and 10% glacial acetic acid.
Antimicrobial Spectrum of Bacillus licheniformis Lysozyme
For the agar diffusion test [17,24], 200 μl of bacterial suspension (approximately 5 × 107 cells) was spread on LB agar plates. Freshly mixed specimens (in triplicate) of each test material were placed in holes 5 mm in diameter that were punched into the agar plate. After incubating at 37℃ for 24 h, the agar plates were examined for bacterial growth inhibition. The diameter of the halo formed in the bacterial lawn was measured (mm) in two perpendicular locations for each specimen.
Results
Isolated Bacterial Strain and Sequence Analysis of Lysozyme
The strain of B. licheniformis TIB320 was isolated from soil in Tianjin, China. The 16S rDNA sequence of B. licheniformis TIB320 (1,510 bp) showed high similarity (99.9%) with B. licheniformis DSM13/ATCC 14580. The gene encoding lysozyme was amplified by PCR and cloned into the pMD19-T vector. Sequence analysis of the B. licheniformis TIB320 lysozyme gene showed that the amino acid sequence of protein shared 90% identity with that from the lysozyme gene of B. licheniformis DSM13/ATCC 14580 (KEGG).
Expression and Purification of Bacillus licheniformis Lysozyme in E. coli
The lysozyme gene was amplified by PCR without the stop codon and cloned into plasmid pET21b with an C-terminal His-tag fusion. The resulting plasmid was introduced into E. coli, and lysozyme expression was induced by the addition of IPTG. The induced E. coli BL21(DE3) cells harboring pET21b-lyso were lysed and resuspended in Tris-HCl buffer.
To test the lysozyme expression, whole cell lysate and the soluble fraction of cell lysate were analyzed by SDS-PAGE. From this result, we knew the expressed lysozyme was approximately 70% of the total cellular protein, and the ratio of the soluble to insoluble fractions of lysozyme was about 1:2 (Fig. 2). The his-tagged lysozyme, as determined from the SDS-polyacrylamide gel image, was purified by a Ni-NTA-HP resin column, and the purified protein was observed as a single band on the SDS-polyacrylamide gel (Fig. 2).
Fig. 2.SDS-PAGE analysis of lysozyme expression in E. coli. SDS-PAGE was performed on a 12% gel and stained with Coomassie Brilliant Blue. Lanes 1, E. coli pET21b-lyso whole cell lysate; lanes 2, Soluble fraction of E. coli pET21b-lyso cell lysate; lane 3, Purified lysozyme; lane M, maker.
Characterization and Activity of B. licheniformis TIB320 Lysozyme
The optimal pH value of the lysozyme activity was examined in the range of 3.0 to 9.0 at 40℃. Lysozyme was exposed to various pHs to find out the optimal pH of B. licheniformis TIB320 lysozyme. Enzymatic activity assay showed that lysozyme retained maximum activity at pH 6 (Fig. 3A) and 65% of the activity was retained at pH 9. However, the activity was decreased to 63% at pH 3.0 (Fig. 3A). To test the optimal temperature of the lysozyme activity, the temperature was ranged from 20℃ to 80℃ at the pH of 6. Results showed the optimal temperature was at 40℃ (Fig. 3B). To examine if the lysozyme can be used as a feed additive, the lysozyme was incubated with trypsin or pepsin at various concentrations up to 400 mg/l, respectively (Fig. 4). The lysozyme was resistant to the trysin and pepsin to some extent and maintained about 50% of activity at 300 mg/l of trypsin and pepsin (Fig. 4).
Fig. 3.Effect of pH (A) and temperature (B) on the activity of lysozyme.
Fig. 4.Effect of trypsin/pepsin concentration on the activity of lysozyme at 40℃ for 1 h.
Antimicrobial Spectrum of B. licheniformis TIB320 Lysozyme
We used the agar diffusion test to analyze the B. licheniformis TIB320 lysozyme antimicrobial activity. In the frame of this research survey, various bacteria were examined regarding their susceptibility against the lysozyme. From Table 3, we know that the lysozyme not only can inhibit gram-positive bacteria such as Micrococcus lysodeikticus, but also showed inhibition zones against pathogenic gram-negative bacteria, such as Salmonella Typhimurium and Pseudomonas aeruginosa (Table 3). Saccharomyces cerevisiae was only slightly sensitive to the lysozyme, as was Aspergillus oryzae (Table 3). Bacillus subtilis seemed to tolerate higher concentrations of the lysozyme probably because of its peptidoglycan modification. It has many advantages of protein expression by using Bacillus subtilis as a host, so we expressed the B. licheniformis TIB320 lysozyme in Bacillus subtilis.
Table 3.aInhibition zone including the 5 mm hole punched into the agar plate.
Expression of Bacillus licheniformis Lysozyme in Bacillus subtilis WB800
Expression of lysozyme in E. coli showed a high amount of production, but a certain amount of protein was inclusion body. To solve this problem, Bacillus subtilis was implemented as a secretory expression host. As described above, plasmid pGJ201 was constructed by fusing the P43 promoter, amylase signal peptide, and lysozyme gene in order with overlap PCR and then inserted into plasmid pGJ103 (Fig. 1). The selected Bacillus subtilis transformants were cultured in a shake flask and the lysozyme activity in the medium was measured (Table 4). After culture for 12 h at 37℃, lysozyme activity was obviously observed, whereas no activities were measured in the controls. We analyzed the expression of lysozyme by the Hultmark method. As depicted in Table 4, the activity of lysozyme increased with culture growth.
Table 4.Yield of lysozyme expression in B. subtilis (U/ml).
Signal peptide is an important factor to target the purpose protein to the membrane, and it also affects the protein secretion efficiency. To secrete more lysozyme to the medium in B. subtilis WB800, amylase signal peptide was replaced by sacB signal peptide. From Table 4, we can see that sacB signal peptide was better than amylase signal peptide in secretion of lysozyme. Therefore, sacB signal peptide was used for the following experiments. Besides the signal peptide, the transcriptional level is also a major factor to determine the protein amount. To enhance the lysozyme production by increasing its gene transcript, we constructed pGJ203 by fusing the P43 promoter and sacB promoter upstream of the lysozyme gene to enhance the transcription. After fermentation for 24 h, the lysozyme production amount in B. subtilis (pGJ203) was significantly higher than that from B. subtilis (pGJ202) (Table 4). It was obvious that the expression of lysozyme was improved by the P43-sacB tandem promoter strategy, increasing the transcript of the lysozyme gene [4].
Regards comparison of the growth of Bacillus subtilis WB800 with various expression vectors, respectively, all strains could grow well in the medium (Fig. 5). The growth rates of Bacillus subtilis WB800 harboring different expression vectors were slightly slower than that of the strain with empty vector, but the production of the lysozyme did not affect the strain growth clearly (Fig. 5). Therefore, Bacillus subtilis WB800 was a suitable strain to produce this lysozyme.
Fig. 5.Growth curve of B. subtilis expressing various plasmids.
Discussion
Lysozyme is not only the most powerful antibacterial agent found in various tissues and secretions of organisms, but is also present in a number of bacteria. Most antibacterial agents had limited antimicrobial spectra. For getting a better antimicrobial enzyme, we have conducted an extensive screening and isolated a strain that contains a lysozyme gene. Identification of the strain by 16S rDNA indicates it belongs to Bacillus licheniformis, which is generally regarded as safe.
Food market globalization, new manufacturing processes, and the growing demand for minimally processed, fresh-cut, and ready-to-eat products may require a longer and more complex food chain, increasing the risk of microbiological contamination. Among alternative food preservation technologies, special attention has been paid to biopreservation to extent the shelf-life and to improve the hygienic quality. Biopreservation rationally exploits the antimicrobial potential of naturally occurring micro-organisms in food and/or their metabolites with a long history of safe use. Lysozyme falls in this concept.
From the results of this article, the lysozyme of Bacillus licheniformis TIB320 had good effects against both gram-positive and gram-negative bacteria, such as Micrococcus lysodeikticus, Clostridium sporogenes, Pseudomonas aeruginosa, etc. Compared with egg white lysozyme [7], which can mainly inhibit gram-positive organisms, Bacillus licheniformis TIB320 lysozyme had a broader antimicrobial spectrum. In particular, Salmonella Typhimurium is a pathogenic gram-negative bacterium predominately found in the intestinal lumen. Its toxicity is due to an outer membrane consisting largely of lipopolysaccharides that protect the bacteria from the environment. Pseudomonas aeruginosa is a gram-negative, rod-shaped bacterium and is an opportunistic human pathogen. It is always listed as one of the top three most frequent gram-negative pathogens [30]. Inhibition activity of lysozyme to these pathogenic bacteria indicated a potential application of the enzyme as a food and feed preservative. This new Bacillus licheniformis lysozyme can maintain sufficient activity in a wide range of pH and temperature values, from pH 3 to 9 and 20℃ to 60℃, respectively. The features of maintaining high activity at low pH and resistance to pepsin and trypsin would be a promising application for food and feed additives.
Industrial production of hen egg white lysozyme benefits large-scale purification of thousands of kilogram of chicken eggs [31]. However, the production of natural lysozymes in bacteria is limited by the inefficient protein expression system. Previous works in E. coli have produced inactive small quantities of enzyme or have been hampered by the isolation of inclusion bodies and refolding, which is inefficient [3,9,16,23]. Several studies have been performed in yeast-based systems and moderate yields have been described in some of these hosts [8,18].
Because eukaryotic proteins as well as hen egg white lysozyme formed inactive material in insoluble inclusion bodies when expressed in E. coli [10,22], it has been suggested that a lack of mammalian post-translational modifying enzymes and foldases causes the formation of inclusion bodies in E. coli. Recent work described a novel and efficient expression system capable of producing folded, soluble, and functional human lysozyme in Escherichia coli cells by simultaneously co-expressing multiple protein folding chaperones as well as the lysozyme inhibitory protein [16].
We expressed B. licheniformis TIB320 lysozyme in E. coli and the lysozyme activity was detected in the soluble cytosolic fraction. However, a certain amount of inclusion bodies were also observed in the insoluble form by SDS-PAGE. One reason for the formation of inclusion bodies could be the high expression rate of the protein, which does not have enough chaperones or foldases to form the native structure and correct folding of the polypeptide chain.
Motivated by the excellent fermentation properties, high product yields, and the complete lack of toxic byproducts of Bacillus subtilis, we sought to develop an efficient expression system for lysozymes in this bacterial host. Moreover, Bacillus subtilis vegetative cells have evolved mechanisms to evade or subvert the lysozyme threat by peptidoglycan modification [36]. In contrast to the secreted production of homologous proteins, the secretion of heterologous proteins is usually inefficient. The most immediate bottleneck of lysozyme expression in B. subtilis is the transcriptional level and protein secretion pathway. To overcome these barriers, the P43 promoter and amylase signal peptide were fused to the lysozyme gene and then expressed in B. subtilis. The activity of lysozyme was successfully detected, which indicated that heterogeneous expression of the enzyme was promising in B. subtilis. The signal peptide is a critical factor to target the enzyme to the membrane, and the protein secretion efficiency varies greatly owing to different signal peptide components. To improve the protein secretion level, amylase signal peptide was replaced by sacB signal peptide and the secretion level of e nzyme w as i nc reased t o some e xtent. I n an e ffort to improve the production and secretion of lysozyme yields further, we constructed a tandem promoter by fusing promoter P43 and promoter sacB. The lysozyme activity was significantly increased in the B. subtilis (pGJ203) with the tandem promoter compared with that in the strain with a single promoter. From these results, we know that the lysozyme was expressed well in the strain with plasmid pGJ203. It is suitable for expression of the microbial lysozyme gene by a food-grade host such as B. subtilis.
The secretion of lysozyme showed slight effect on the growth of B. subtilis in this study. A lysozyme inhibitor can sequester the lysozyme’s inherent bactericidal activity and protect the expression host [1,19]. To further increase the yield of lysozyme and protect our B. subtilis host from the toxic effect of lysozyme expression, co-expression of a lysozyme inhibitor could be a solution to this problem in future work.
References
- Abergel C, Monchois V, Byrne D, Chenivesse S, Lembo F, Lazzaroni JC, Claverie JM. 2007. Structure and evolution of the Ivy protein family, unexpected lysozyme inhibitors in gram-negative bacteria. Proc. Natl. Acad. Sci. USA 104: 6394-6399. https://doi.org/10.1073/pnas.0611019104
- Callewaert L, Michiels CW. 2010. Lysozymes in the animal kingdom. J. Biosci. 35: 127-160. https://doi.org/10.1007/s12038-010-0015-5
- Casaite V, Bruzyte S, Bukauskas V, Setkus A, Morozova- Roche LA, Meskys R. 2009. Expression and purification of active recombinant equine lysozyme in Escherichia coli. Protein Eng. Des. Sel. 22: 649-654. https://doi.org/10.1093/protein/gzp048
- Chiang CJ, Chen PT, Chao YP. 2010. Secreted production of Renilla luciferase in Bacillus subtilis. Biotechnol. Prog. 26: 589-594.
- Dong H, Zhang D. 2014. Current development in genetic engineering strategies of Bacillus species. Microb. Cell Fact. 13: 63. https://doi.org/10.1186/1475-2859-13-63
- During K. 1993. A tightly regulated system for overproduction of bacteriophage T4 lysozyme in Escherichia coli. Protein Expr. Purif. 4: 412-416. https://doi.org/10.1006/prep.1993.1054
- Ellison RT 3rd, Giehl TJ. 1991. Killing of gram-negative bacteria by lactoferrin and lysozyme. J. Clin. Invest. 88: 1080-1091. https://doi.org/10.1172/JCI115407
- Ercan D, Demirci A. 2013. Production of human lysozyme in biofilm reactor and optimization of growth parameters of Kluyveromyces lactis K7. Appl. Microbiol. Biotechnol. 97: 6211-6221. https://doi.org/10.1007/s00253-013-4944-4
- Fischer B, Perry B, Phillips G, Sumner I, Goodenough P. 1993. Physiological consequence of expression of soluble and active hen egg white lysozyme in Escherichia coli. Appl. Microbiol. Biotechnol. 39: 537-540. https://doi.org/10.1007/BF00205047
- Fischer B, Perry B, Sumner I, Goodenough P. 1992. A novel sequential procedure to enhance the renaturation of recombinant protein from Escherichia coli inclusion bodies. Protein Eng. 5: 593-596. https://doi.org/10.1093/protein/5.6.593
- Goto T, Abe Y, Kakuta Y, Takeshita K, Imoto T, Ueda T. 2007. Crystal structure of Tapes japonica lysozyme with substrate analogue: structural basis of the catalytic mechanism and manifestation of its chitinase activity accompanied by quaternary structural change. J. Biol. Chem. 282: 27459-27467. https://doi.org/10.1074/jbc.M704555200
- Hayano T, Hirose M, Kikuchi M. 1995. Protein disulfide isomerase mutant lacking its isomerase activity accelerates protein folding in the cell. FEBS Lett. 377: 505-511. https://doi.org/10.1016/0014-5793(95)01410-1
- Hultmark D, Steiner H, Rasmuson T, Boman HG. 1980. Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur. J. Biochem. 106: 7-16.
- Jolles P, Jolles J. 1984. What's new in lysozyme research? Always a model system, today as yesterday. Mol. Cell. Biochem. 63: 165-189.
- Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685. https://doi.org/10.1038/227680a0
- Lamppa JW, Tanyos SA, Griswold KE. 2013. Engineering Escherichia coli for soluble expression and single step purification of active human lysozyme. J. Biotechnol. 164: 1-8. https://doi.org/10.1016/j.jbiotec.2012.11.007
- Lewinstein I, Matalon S, Slutzkey S, Weiss EI. 2005. Antibacterial properties of aged dental cements evaluated by direct-contact and agar diffusion tests. J. Prosthet. Dent. 93: 364-371. https://doi.org/10.1016/j.prosdent.2005.01.008
- Maullu C, Lampis G, Desogus A, Ingianni A, Rossolini GM, Pompei R. 1999. High-level production of heterologous protein by engineered yeasts grown in cottage cheese whey. Appl. Environ. Microbiol. 65: 2745-2747.
- Monchois V, Abergel C, Sturgis J, Jeudy S, Claverie JM. 2001. Escherichia coli ykfE ORFan gene encodes a potent inhibitor of C-type lysozyme. J. Biol. Chem. 276: 18437-18441. https://doi.org/10.1074/jbc.M010297200
- Petsch D, Anspach FB. 2000. Endotoxin removal from protein solutions. J. Biotechnol. 76: 97-119. https://doi.org/10.1016/S0168-1656(99)00185-6
- Qasba PK, Kumar S. 1997. Molecular divergence of lysozymes and alpha-lactalbumin. Crit. Rev. Biochem. Mol. Biol. 32: 255-306. https://doi.org/10.3109/10409239709082574
- Sawano H, Koumoto Y, Ohta K, Sasaki Y, Segawa S, Tachibana H. 1992. Efficient in vitro folding of the threedisulfide derivatives of hen lysozyme in the presence of glycerol. FEBS Lett. 303: 11-14. https://doi.org/10.1016/0014-5793(92)80466-T
- Schlorb C, Ackermann K, Richter C, Wirmer J, Schwalbe H. 2005. Heterologous expression of hen egg white lysozyme and resonance assignment of tryptophan side chains in its non-native states. J. Biomol. NMR 33: 95-104. https://doi.org/10.1007/s10858-005-2063-y
- Schwartzman B, Caputo AA, Schein B. 1980. Antimicrobial action of dental cements. J. Prosthet. Dent. 43: 309-312. https://doi.org/10.1016/0022-3913(80)90407-2
- Simonen M, Palva I. 1993. Protein secretion in Bacillus species. Microbiol. Rev. 57: 109-137.
- van Dijl JM, Hecker M. 2013. Bacillus subtilis: from soil bacterium to super-secreting cell factory. Microb. Cell Fact. 12: 3. https://doi.org/10.1186/1475-2859-12-3
- Wang F, Qu H, Zhang D, Tian P, Tan T. 2007. Production of 1,3-propanediol from glycerol by recombinant E. coli using incompatible plasmids system. Mol. Biotechnol. 37: 112-119. https://doi.org/10.1007/s12033-007-0041-1
- Wei JT, Tang CD, Wu MC, Liu GL, Shi HL, Li JF. 2012. Cloning and functional expression of a human lysozyme gene (hly) from human leukocytes in Pichia pastoris. Mol. Med. Rep. 6: 173-178.
- Westers L, Westers H, Quax WJ. 2004. Bacillus subtilis as cell factory for pharmaceutical proteins: a biotechnological approach to optimize the host organism. Biochim. Biophys. Acta 1694: 299-310. https://doi.org/10.1016/j.bbamcr.2004.02.011
- Wiehlmann L, Wagner G, Cramer N, Siebert B, Gudowius P, Morales G, et al. 2007. Population structure of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 104: 8101-8106. https://doi.org/10.1073/pnas.0609213104
- Wilken LR, Nikolov ZL. 2011. Process evaluations and economic analyses of recombinant human lysozyme and hen egg-white lysozyme purifications. Biotechnol. Prog. 27: 733-743. https://doi.org/10.1002/btpr.593
- Yeh CM, Yeh CK, Hsu XY, Luo QM, Lin MY. 2008. Extracellular expression of a functional recombinant Ganoderma lucidium immunomodulatory protein by Bacillus subtilis and Lactococcus lactis. Appl. Environ. Microbiol. 74: 1039-1049. https://doi.org/10.1128/AEM.01547-07
- Zhang D, Shan SO. 2012. Translation elongation regulates substrate selection by the signal recognition particle. J. Biol. Chem. 287: 7652-7660. https://doi.org/10.1074/jbc.M111.325001
- Zhang D, Shrestha B, Li Z, Tan T. 2007. Ubiquinone-10 production using Agrobacterium tumefaciens dps gene in Escherichia coli by coexpression system. Mol. Biotechnol. 35: 1-14. https://doi.org/10.1385/MB:35:1:1
- Zhang D, Sweredoski MJ, Graham RL, Hess S, Shan SO. 2012. Novel proteomic tools reveal essential roles of SRP and importance of proper membrane protein biogenesis. Mol. Cell. Proteomics 11: M111 011585. https://doi.org/10.1074/mcp.M111.011585
- Zipperle GF Jr, Ezzell JW Jr, Doyle RJ. 1984. Glucosamine substitution and muramidase susceptibility in Bacillus anthracis. Can. J. Microbiol. 30: 553-559. https://doi.org/10.1139/m84-083
Cited by
- A rapid enzymatic assay for high-throughput screening of adenosine-producing strains vol.8, pp.2, 2014, https://doi.org/10.1111/1751-7915.12189
- Enhanced extracellular production of α-amylase in Bacillus subtilis by optimization of regulatory elements and over-expression of PrsA lipoprotein vol.37, pp.4, 2014, https://doi.org/10.1007/s10529-014-1755-3
- High-Efficiency Secretion of β-Mannanase in Bacillus subtilis through Protein Synthesis and Secretion Optimization vol.65, pp.12, 2017, https://doi.org/10.1021/acs.jafc.6b05528
- A food-grade expression system for D -psicose 3-epimerase production in Bacillus subtilis using an alanine racemase-encoding selection marker vol.4, pp.None, 2014, https://doi.org/10.1186/s40643-017-0139-7
- Genetic and substrate-level modulation of Bacillus subtilis physiology for enhanced extracellular human interferon gamma production vol.48, pp.5, 2014, https://doi.org/10.1080/10826068.2018.1446157
- The Goldilocks Approach: A Review of Employing Design of Experiments in Prokaryotic Recombinant Protein Production vol.5, pp.4, 2014, https://doi.org/10.3390/bioengineering5040089
- Systematic Screening of Optimal Signal Peptides for Secretory Production of Heterologous Proteins in Bacillus subtilis vol.66, pp.50, 2018, https://doi.org/10.1021/acs.jafc.8b04183
- Newly identified C‐type lysozyme in Chinese soft‐shelled turtle (Pelodiscus sinensis) exhibits potent antimicrobial activity vol.50, pp.10, 2014, https://doi.org/10.1111/are.14235
- Isolation of a broad spectrum antimicrobial producing thermophilic Bacillus and characterization of its antimicrobial protein vol.203, pp.5, 2014, https://doi.org/10.1007/s00203-020-02162-w
- Applications of Lysozyme, an Innate Immune Defense Factor, as an Alternative Antibiotic vol.10, pp.12, 2014, https://doi.org/10.3390/antibiotics10121534